Goals of the Network

IBD Research in Ireland

To foster collaboration and encourage multi-centre investigator initiated studies in Crohn’s Disease and Ulcerative Colitis in Ireland

Clinical Trials

To attract and facilitate industry sponsored clinical trials in Crohn’s Disease and Ulcerative Colitis in Ireland in order to improve the access for patients in Ireland to investigational drugs and therapies

Global Research Collaboration

To foster European, and Global collaboration in IBD research and improve the profile of IBD related research taking place in Ireland

Participation

To facilitate participation by Irish IBD investigators in European research consortia and networks

Investment

To attract funding for an investment in research infrastructure to support research in Crohn’s Disease and Ulcerative Colitis in Ireland

INITIative is the first collaborative research network for Inflammatory Bowel Disease in Ireland. The network is open to clinical and scientific investigators with an interest in Crohn’s Disease and Ulcerative Colitis throughout the island of Ireland.

Studies

BODPOD-IBD

BODPOD-IBD

Use of Air Displacement Plethysmography to Measure Body Composition in Patients with Inflammatory Bowel Disease and Examining Associations with Disease Activity

TOAST-IBD

TOAST-IBD

Treatment related Outcomes Associated with SToma in IBD: Developing core outcomes measures for intervention studies in patients with IBD who have stomas

HARP-X

HARP-X

Healing of Antibiotic Refractory Pouchitis with Xeljanz for those with active, chronic, antibiotic dependent or refractory pouchitis

VARIATION

VARIATION

Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy

MOBIDIC

MOBIDIC

Molecular Biomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection study In Crohn’s disease patients

I-CARE

I-CARE

IBD CAncer and seRious infections in Europe

GOAL-ARC

GOAL-ARC

Golimumab dose Optimisation to Adequate Levels to Achieve Response in Colitis

STEIG

STEIG

Stelara Treatment Effectiveness in Irish Gastroenterology

SECURE-IBD

SECURE-IBD

Surveillance Epidemiology of Coronavirus Under Research Exclusion in Inflammatory Bowel Disease